findmyKOL

Eddys Disla, MD

Basic profile

Mount Sinai Beth Israel

ORCIDNone on fileNPI↗
✓ Full record
RegionNew York, NY · NortheastSpecialtyRheumatologyFocusRheumatology/Immunology
Active KOLfindmyKOL type: RegionalLatest publication2019Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Eddys Disla is a Rheumatology/Immunology physician affiliated with Mount Sinai Beth Israel. OpenAlex indexes 21 publications with 310 citations (h-index 9).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
21publications

Distinct works indexed by OpenAlex.

310citations

Total citations across indexed works.

9h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
20companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1st Ave & E 16th St
7th Floor
New York, NY 10003

Telephone

212-420-3131

Registry record last updated 17 Apr 2019.

View the NPPES registry record

Industry payments

20 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    28.4%
    Aminosalicylate6%
    Sulfasalazine94%Sulfasalazine Dr6%
    Part D≥222 patients
    Provitamin D2 Compound5.9%
    Vitamin D2100%
    Part D≥238 patients

    + 18 more classes in this area

  • Cardiovascular

    21.1%
    Statin5.5%
    Atorvastatin Calcium42%Rosuvastatin Calcium32%Pravastatin Sodium16%Simvastatin10%
    Part D≥122 patients
    Beta blocker4.2%
    Carvedilol46%Metoprolol Succinate28%Metoprolol Tartrate8%Bisoprolol Fumarate5%Atenolol5%Timolol Maleate3%Propranolol Hcl2%Labetalol Hcl1%Bystolic1%
    Part D<11 patients

    + 17 more classes in this area

  • Nervous system

    10.3%
    Gabapentinoids4.2%
    Gabapentin96%Pregabalin4%
    Part D<11 patients
    SSRI2.1%
    Sertraline Hcl58%Trazodone Hcl18%Escitalopram Oxalate9%Citalopram Hbr8%Paroxetine Hcl7%
    Part D<11 patients

    + 15 more classes in this area

Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”